
Greenlane Holdings GNLN
$ 1.57
-14.67%
Quarterly report 2025-Q3
added 11-14-2025
Greenlane Holdings Gross Profit 2011-2026 | GNLN
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Greenlane Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 25 M | 33.9 M | 22.8 M | 31.1 M | 35.7 M | 20.6 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.7 M | 20.6 M | 28.2 M |
Quarterly Gross Profit Greenlane Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.1 M | 2 K | 721 K | 3.03 M | 1.01 M | 1.51 M | 3.13 M | 4.57 M | 5.52 M | - | 4.97 M | 8.1 M | 5.97 M | - | 1.49 M | 9.05 M | 8.56 M | - | 2.47 M | 6.82 M | 7.33 M | - | 6.44 M | 9.15 M | 8.99 M | - | 8.87 M | 8.41 M | 9.05 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.15 M | -5.1 M | 5 M |
Gross Profit of other stocks in the Pharmaceutical retailers industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Аптеки 36.6
APTK
|
13.6 B | - | - | - | ||
|
China Jo-Jo Drugstores, Inc.
CJJD
|
25.5 M | - | -5.59 % | $ 49.9 M | ||
|
BOQI International Medical
BIMI
|
1.95 M | - | 6.33 % | $ 5.86 M | ||
|
Trxade Group
MEDS
|
2.6 M | - | 4.55 % | $ 5.8 M | ||
|
PetMed Express
PETS
|
69.1 M | $ 3.2 | -1.54 % | $ 65.9 M | ||
|
111
YI
|
829 M | $ 2.53 | -3.8 % | $ 435 M | ||
|
LifeMD
LFMD
|
134 M | $ 3.41 | -2.29 % | $ 116 M | ||
|
Rite Aid Corporation
RAD
|
4.8 B | - | - | $ 35.5 M | ||
|
Walgreens Boots Alliance
WBA
|
26.5 B | - | - | $ 10.3 B |